Laurent Chardonnet - Jun 1, 2022 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Signature
/s/ Krishna Vaddi, Attorney-in-Fact
Stock symbol
PRLD
Transactions as of
Jun 1, 2022
Transactions value $
$42,300
Form type
4
Date filed
6/1/2022, 04:31 PM
Previous filing
Mar 22, 2022
Next filing
Dec 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRLD Common Stock Purchase $42.3K +10K +68.97% $4.23 24.5K Jun 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.22 to $4.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.